Journal Article

The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients

Marcelo M. Nascimento, Mohamed E. Suliman, Annette Bruchfeld, Shirley Y. Hayashi, Roberto C. Manfro, Abdul Rashid Qureshi, Roberto Pecoits-Filho, Maria A. Pachaly, Luciana Renner, Peter Stenvinkel, Miguel C. Riella and Bengt Lindholm

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 19, issue 12, pages 3112-3116
Published in print December 2004 | ISSN: 0931-0509
Published online October 2004 | e-ISSN: 1460-2385 | DOI:
The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients

Show Summary Details


Background. Chronic liver disease and intravenous (i.v.) iron therapy can enhance oxidative stress. The aim of this study was to assess the influence of hepatitis C virus (HCV) and i.v. iron administration on oxidative stress in chronic haemodialysis (HD) patients.

Methods. A total of 115 HD patients (47% males, age 47±13 years) were placed in two groups according to the presence (HCV+) or absence (HCV) of serum antibodies against HCV. Plasma pentosidine, high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6) and alanine aminotransferase (ALT) levels were measured. The patients were also analysed according to the tertiles of serum levels of ferritin: group 1 (ferritin <380 ng/ml), group 2 (ferritin 380–750 ng/ml) and group 3 (ferritin >750 ng/ml). The cumulative iron dose was recorded during 6 months prior to the study.

Results. HCV+ patients had significantly higher levels of plasma pentosidine and ALT than HCV patients. Age, gender, serum albumin, IL-6 and hsCRP did not differ according to HCV serology. The levels of pentosidine were related to the ferritin levels and were significantly higher in group 3 compared with group 1. Moreover, the cumulative dose of iron was significantly higher in group 3 than in group 1. Plasma pentosidine showed a positive correlation with age, HCV and ferritin. In a stepwise backward multiple regression model, age and HCV were independent predictors of pentosidine levels.

Conclusion. HCV in HD patients is associated with increased pentosidine levels, possibly reflecting increased oxidative stress. The association between pentosidine and ferritin levels may suggest an impact of i.v. iron therapy.

Keywords: ferritin; haemodialysis; hepatitis C; oxidative stress; pentosidine

Journal Article.  3349 words. 

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.